Dimethylbenzanthracene treatment of bone marrow stromal cells causes cytochrome P4501B1 dependent preB cell apoptosis

被引：0
|
作者：
Heidel, SM
Jefcoate, CR
Baird, WM
Czuprynski, CJ
机构：
[1] Oregon State Univ, Corvallis, OR 97331 USA
[2] Univ Wisconsin, Madison, WI 53706 USA
来源：
FASEB JOURNAL | 1999年 / 13卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A330 / A330
页数：1
相关论文
共 50 条
  • [21] Characterization and functional analysis of 5 human cytochrome P4501B1 variants
    Bandiera, S
    Freidberg, T
    DRUG METABOLISM REVIEWS, 2003, 35 : 132 - 132
  • [22] Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P4501B1
    Choudhary, D
    Jansson, I
    Stoilov, I
    Sarfarazi, M
    Schenkman, JB
    DRUG METABOLISM AND DISPOSITION, 2004, 32 (08) : 840 - 847
  • [23] Association of functionally important polymorphisms in cytochrome P4501B1 with lung cancer
    Shah, Parag P.
    Singh, Arvind P.
    Singh, Madhu
    Mathur, Neeraj
    Mishra, Bhartendu N.
    Pant, Mohan C.
    Parmar, Devendra
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2008, 643 (1-2) : 4 - 10
  • [24] Cytochrome P4501B1 in bone marrow is co-expressed with key markers of mesenchymal stem cells. BMS2 cell line models PAH disruption of bone marrow niche development functions
    Larsen, Michele Campaigne
    Almeldin, Ahmed
    Tong, Tiegang
    Rondelli, Catherine M.
    Maguire, Meghan
    Jaskula-Sztul, Renata
    Jefcoate, Colin R.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2020, 401
  • [25] Coumarins are competitive inhibitors of cytochrome P4501B1, with equal potency for allelic variants
    Mammen, JS
    Kleiner, HE
    DiGiovanni, J
    Sutter, TR
    Strickland, PT
    PHARMACOGENETICS AND GENOMICS, 2005, 15 (03): : 183 - 188
  • [26] Cytochrome P4501B1 gene mutations Japanese patients with primary congenital glaucoma
    Kakiuchi-Matsumoto, T
    Isashiki, Y
    Ohba, N
    Kimura, K
    Sonoda, S
    Unoki, K
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2001, 131 (03) : 345 - 350
  • [27] The role of cytochrome P4501B1 in dibenzo[a,l]lipyrene-induced carcinogenesis
    Luch, A
    Greim, H
    Buters, JTM
    Mahadevan, B
    Baird, WM
    Doehmer, J
    Seidel, A
    Glatt, H
    POLYCYCLIC AROMATIC COMPOUNDS, 2002, 22 (3-4) : 781 - 789
  • [28] Regioselective 2-hydroxylation of 17β-estradiol by rat cytochrome P4501B1
    Rahman, Mostafizur
    Sutter, Carrie Hayes
    Emmert, Gary L.
    Sutter, Thomas R.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2006, 216 (03) : 469 - 478
  • [29] The shared tumor-associated antigen cytochrome P4501B1 is recognized by specific cytotoxic T cells
    Maecker, B
    Sherr, DH
    Vonderheide, RH
    von Bergwelt-Baildon, MS
    Hirano, N
    Anderson, KS
    Xia, ZN
    Butler, MO
    Wucherpfennig, KW
    O'Hara, C
    Cole, G
    Kwak, SS
    Ramstedt, U
    Tomlinson, AJ
    Chicz, RM
    Nadler, LM
    Schultze, JL
    BLOOD, 2003, 102 (09) : 3287 - 3294
  • [30] Modulation of human cytochrome P4501B1 by tetrametboxystilbene in mammary tumor cells and its application for cancer chemotherapy
    Chun, YJ
    Lee, SK
    Kim, MY
    FASEB JOURNAL, 2003, 17 (05): : A1325 - A1325
12345